Illumina Body Map 2 (GSE30611)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_216695540 Show fit | 2.06 |
ENST00000233813.5
|
insulin like growth factor binding protein 5 |
|
chr3_+_139935176 Show fit | 1.94 |
ENST00000458420.7
|
calsyntenin 2 |
|
chr19_-_35757009 Show fit | 0.92 |
ENST00000587965.1
ENST00000004982.6 |
heat shock protein family B (small) member 6 |
|
chr12_-_49903853 Show fit | 0.82 |
ENST00000320634.8
|
Fas apoptotic inhibitory molecule 2 |
|
chr3_-_12158901 Show fit | 0.82 |
ENST00000287814.5
|
TIMP metallopeptidase inhibitor 4 |
|
chr3_-_112641128 Show fit | 0.74 |
ENST00000206423.8
|
coiled-coil domain containing 80 |
|
chr17_-_80035862 Show fit | 0.72 |
ENST00000310924.7
|
TBC1 domain family member 16 |
|
chr21_-_41926680 Show fit | 0.68 |
ENST00000329623.11
|
C2 calcium dependent domain containing 2 |
|
chr11_+_118606428 Show fit | 0.64 |
ENST00000361417.6
|
pleckstrin homology like domain family B member 1 |
|
chr7_+_31052297 Show fit | 0.60 |
ENST00000304166.9
|
ADCYAP receptor type I |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.3 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.7 | 2.1 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.0 | 0.9 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.8 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.7 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.0 | 0.7 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.6 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.1 | 0.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.0 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.1 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.0 | 0.0 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.4 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
0.1 | 0.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |